Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-007255
Filing Date
2024-06-27
Accepted
2024-06-27 10:36:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27640
2 filename2.txt TEXT-EXTRACT 1479
  Complete submission text file 0000000000-24-007255.txt   40616
Mailing Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 601 BALTIMORE MD 21205 856-848-8698
TNF Pharmaceuticals, Inc. (Filed for) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-280415
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)